MassIVE MSV000100813

Partial Public PXD074376

CFH_Interactome : P53 and cell cycle control by an intracellular form of complement Factor H

Description

Overexpression of complement genes in the tumor microenvironment, including Factor H (FH), has emerged as a strong predictor of poor patient prognosis. While its canonical role as a negative regulator of the complement cascade is well-known, this alone cannot fully account for this prognostic impact. This study reveals that FH operates in a cascade-independent fashion within fibroblasts and clear cell renal cell carcinoma (ccRCC) tumor cells, where it is overexpressed under pro-tumoral inflammatory conditions. FH prognostic impact stems from its intracellular functions in tumor-promoting fibroblasts and malignant cells. FH, which has a nuclear localization signal, was found in the nucleus, cytosol and organelle fractions of both fibroblasts and ccRCC cells. Co-immunoprecipitation and mass spectrometry identified FH interactions with the cell cycle-transcription factor E2F3. FH accelerates cell cycle progression by preventing p53 activation, potentially through blocking E2F3-p53 interactions at the G1/S transition. In addition, in tumor cells, FH interacts with CapZ to regulate actin cytoskeleton. Finally, transcriptional trajectory analyses of ccRCC malignant cells revealed a CFH enriched cell state linked to proliferation and poor patient prognosis, consistent with increased Ki67 staining in FH-positive cancer cells from patient tumors. Together, these results position FH as a novel tumor-promoting effector of cell cycle through modulation of p53 [doi:10.25345/C5M61C37T] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Mass spectrometry ; DIA ; CFH ; Proteins Inetarction ; IP_MS ; DatasetType:Proteomics

Contact

Principal Investigators:
(in alphabetical order)
Mohamed Ali Jarboui, University klinikum Tuebingen, Germany
Submitting User: Dali77
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
Browse Metadata
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.